279 related articles for article (PubMed ID: 26351223)
1. Posterior fossa ependymoma: current insights.
Thompson YY; Ramaswamy V; Diamandis P; Daniels C; Taylor MD
Childs Nerv Syst; 2015 Oct; 31(10):1699-706. PubMed ID: 26351223
[TBL] [Abstract][Full Text] [Related]
2. Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma.
Wu T; Zhang ZW; Li S; Wang B; Yang Z; Li P; Zhang J; Tong WM; Li C; Zhao F; Niu Y; Liu P
Clin Epigenetics; 2020 Jan; 12(1):19. PubMed ID: 31992357
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity within the PF-EPN-B ependymoma subgroup.
Cavalli FMG; Hübner JM; Sharma T; Luu B; Sill M; Zapotocky M; Mack SC; Witt H; Lin T; Shih DJH; Ho B; Santi M; Emery L; Hukin J; Dunham C; McLendon RE; Lipp ES; Gururangan S; Grossbach A; French P; Kros JM; van Veelen MC; Rao AAN; Giannini C; Leary S; Jung S; Faria CC; Mora J; Schüller U; Alonso MM; Chan JA; Klekner A; Chambless LB; Hwang EI; Massimino M; Eberhart CG; Karajannis MA; Lu B; Liau LM; Zollo M; Ferrucci V; Carlotti C; Tirapelli DPC; Tabori U; Bouffet E; Ryzhova M; Ellison DW; Merchant TE; Gilbert MR; Armstrong TS; Korshunov A; Pfister SM; Taylor MD; Aldape K; Pajtler KW; Kool M; Ramaswamy V
Acta Neuropathol; 2018 Aug; 136(2):227-237. PubMed ID: 30019219
[TBL] [Abstract][Full Text] [Related]
4. Treatment implications of posterior fossa ependymoma subgroups.
Ramaswamy V; Taylor MD
Chin J Cancer; 2016 Nov; 35(1):93. PubMed ID: 27846874
[TBL] [Abstract][Full Text] [Related]
5. Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort.
Jünger ST; Mynarek M; Wohlers I; Dörner E; Mühlen AZ; Velez-Char N; von Hoff K; Rutkowski S; Warmuth-Metz M; Kortmann RD; Timmermann B; Rahmann S; Klein-Hitpass L; von Bueren AO; Pietsch T
Acta Neuropathol Commun; 2019 Nov; 7(1):181. PubMed ID: 31727173
[TBL] [Abstract][Full Text] [Related]
6. The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated?
Paulino AC
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):757-61. PubMed ID: 11172959
[TBL] [Abstract][Full Text] [Related]
7. Posterior fossa ependymoma with intense but transient disseminated enhancement but not metastasis.
Butler WE; Khan A; Khan SA
Pediatr Neurosurg; 2002 Jul; 37(1):27-31. PubMed ID: 12138216
[TBL] [Abstract][Full Text] [Related]
8. Uncommon pediatric tumors of the posterior fossa: pathologic and molecular features.
Dunham C
Childs Nerv Syst; 2015 Oct; 31(10):1729-37. PubMed ID: 26351226
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.
Ramaswamy V; Hielscher T; Mack SC; Lassaletta A; Lin T; Pajtler KW; Jones DT; Luu B; Cavalli FM; Aldape K; Remke M; Mynarek M; Rutkowski S; Gururangan S; McLendon RE; Lipp ES; Dunham C; Hukin J; Eisenstat DD; Fulton D; van Landeghem FK; Santi M; van Veelen ML; Van Meir EG; Osuka S; Fan X; Muraszko KM; Tirapelli DP; Oba-Shinjo SM; Marie SK; Carlotti CG; Lee JY; Rao AA; Giannini C; Faria CC; Nunes S; Mora J; Hamilton RL; Hauser P; Jabado N; Petrecca K; Jung S; Massimi L; Zollo M; Cinalli G; Bognár L; Klekner A; Hortobágyi T; Leary S; Ermoian RP; Olson JM; Leonard JR; Gardner C; Grajkowska WA; Chambless LB; Cain J; Eberhart CG; Ahsan S; Massimino M; Giangaspero F; Buttarelli FR; Packer RJ; Emery L; Yong WH; Soto H; Liau LM; Everson R; Grossbach A; Shalaby T; Grotzer M; Karajannis MA; Zagzag D; Wheeler H; von Hoff K; Alonso MM; Tuñon T; Schüller U; Zitterbart K; Sterba J; Chan JA; Guzman M; Elbabaa SK; Colman H; Dhall G; Fisher PG; Fouladi M; Gajjar A; Goldman S; Hwang E; Kool M; Ladha H; Vera-Bolanos E; Wani K; Lieberman F; Mikkelsen T; Omuro AM; Pollack IF; Prados M; Robins HI; Soffietti R; Wu J; Metellus P; Tabori U; Bartels U; Bouffet E; Hawkins CE; Rutka JT; Dirks P; Pfister SM; Merchant TE; Gilbert MR; Armstrong TS; Korshunov A; Ellison DW; Taylor MD
J Clin Oncol; 2016 Jul; 34(21):2468-77. PubMed ID: 27269943
[TBL] [Abstract][Full Text] [Related]
10. Is gross-total resection sufficient treatment for posterior fossa ependymomas?
Rogers L; Pueschel J; Spetzler R; Shapiro W; Coons S; Thomas T; Speiser B
J Neurosurg; 2005 Apr; 102(4):629-36. PubMed ID: 15871504
[TBL] [Abstract][Full Text] [Related]
11. Differential language trajectories following treatment for pediatric posterior fossa tumor: an investigation of four cases.
Lewis FM; Murdoch BE
NeuroRehabilitation; 2013; 32(1):165-83. PubMed ID: 23422470
[TBL] [Abstract][Full Text] [Related]
12. Intellectual outcome in children with malignant tumors of the posterior fossa: influence of the field of irradiation and quality of surgery.
Hoppe-Hirsch E; Brunet L; Laroussinie F; Cinalli G; Pierre-Kahn A; Rénier D; Sainte-Rose C; Hirsch JF
Childs Nerv Syst; 1995 Jun; 11(6):340-5; discussion 345-6. PubMed ID: 7671269
[TBL] [Abstract][Full Text] [Related]
13. Extra-axial ependymoma of posterior fossa extending to the Meckel's cave.
Torun F; Tuna H; Bozkurt M; Deda H
Clin Neurol Neurosurg; 2005 Jun; 107(4):334-6. PubMed ID: 15885395
[TBL] [Abstract][Full Text] [Related]
14. Quantitative imaging analysis of posterior fossa ependymoma location in children.
Sabin ND; Merchant TE; Li X; Li Y; Klimo P; Boop FA; Ellison DW; Ogg RJ
Childs Nerv Syst; 2016 Aug; 32(8):1441-7. PubMed ID: 27117266
[TBL] [Abstract][Full Text] [Related]
15. Infusion of 5-Azacytidine (5-AZA) into the fourth ventricle or resection cavity in children with recurrent posterior Fossa Ependymoma: a pilot clinical trial.
Sandberg DI; Yu B; Patel R; Hagan J; Miesner E; Sabin J; Smith S; Fletcher S; Shah MN; Sirianni RW; Taylor MD
J Neurooncol; 2019 Jan; 141(2):449-457. PubMed ID: 30460634
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
17. Surgery for posterior fossa ependymomas in adults.
Laviv Y; Germano IM; Mahadevan A; Kasper EM
J Neurosurg Sci; 2018 Feb; 62(1):63-70. PubMed ID: 28945053
[TBL] [Abstract][Full Text] [Related]
18. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
[TBL] [Abstract][Full Text] [Related]
19. Utility of copy number variants in the classification of intracranial ependymoma.
Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S
Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.
Panwalkar P; Clark J; Ramaswamy V; Hawes D; Yang F; Dunham C; Yip S; Hukin J; Sun Y; Schipper MJ; Chavez L; Margol A; Pekmezci M; Chung C; Banda A; Bayliss JM; Curry SJ; Santi M; Rodriguez FJ; Snuderl M; Karajannis MA; Saratsis AM; Horbinski CM; Carret AS; Wilson B; Johnston D; Lafay-Cousin L; Zelcer S; Eisenstat D; Silva M; Scheinemann K; Jabado N; McNeely PD; Kool M; Pfister SM; Taylor MD; Hawkins C; Korshunov A; Judkins AR; Venneti S
Acta Neuropathol; 2017 Nov; 134(5):705-714. PubMed ID: 28733933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
